Evidence map›Paper›PMID 35054364›Full record

ArticleDiagnostics (Basel, Switzerland)2022

Comparison of Three Expanded-Spectrum Cephalosporin Hydrolysis Assays and the NG-Test CTX-M Multi Assay That Detects All CTX-M-Like Enzymes.

Camille Gonzalez, Christian Moguet, Arnaud Chalin, Saoussen Oueslati, Laurent Dortet, Stéphanie Simon, Hervé Volland, Thierry Naas

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 11 citations in OpenAlex.

  1. Rapid commercial CTX-M diagnostics: Performance, limitations and clinical impact.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Review
  2. Diagnostic characteristics of the Rapid ESBL NPEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Camille GonzalezTeam "Resist" UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, LabEx LERMIT, 94270 Le Kremlin-Bicêtre, France.
Christian MoguetDépartement Médicaments et Technologies pour la Santé, Université Paris-Saclay, CEA, INRAE, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-6497-4889
Arnaud ChalinResearch and Development Department, NG Biotech, 35480 Guipry, France.
Saoussen OueslatiTeam "Resist" UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, LabEx LERMIT, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0001-5766-3831
Laurent DortetTeam "Resist" UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, LabEx LERMIT, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0001-6596-7384
Stéphanie SimonDépartement Médicaments et Technologies pour la Santé, Université Paris-Saclay, CEA, INRAE, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-6071-8255
Hervé VollandDépartement Médicaments et Technologies pour la Santé, Université Paris-Saclay, CEA, INRAE, 91191 Gif-sur-Yvette, France.ORCID 0000-0001-7165-3218
Thierry NaasTeam "Resist" UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Faculty of Medicine, Université Paris-Saclay, CEA, LabEx LERMIT, 94270 Le Kremlin-Bicêtre, France.ORCID 0000-0001-9937-9572
Inserm · FRCommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRNG Biotech (France) · FR

Funding

Agence Nationale de la Recherche ANR-10-LABX-33Agence Nationale de la Recherche ANR-17-ASTR-0018-03Assistance Publique - Hôpitaux de Paris bacteriologieEuropean Institute of Innovation and Technology AMR-DetectoolInserm 1184University of Paris-Saclay 1184
6 · The paper itself

Abstract

Rapid detection of expanded-spectrum cephalosporins (ESC) hydrolysing enzymes is crucial to implement infection control measures and antibiotic stewardship. Here, we have evaluated three biochemical ESC hydrolysis assays (ESBL NDP test, β-LACTA™ test, LFIA-CTX assay) and the NG-Test

Indexed as

biochemical assayCTX-MESBL detectionexpanded-spectrum cephalosporin hydrolysislateral flow immunoassayLFIArapid diagnostics

Identifiers

PMID35054364
PMCPMC8775164
OpenAlexW4205248734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.